title: Individualizing hormone-therapy according to cardiovascular risk.
abstract: There is growing consensus that the benefit to risk profile for hormone therapy is high for healthy, low-risk women initiating therapy within 10 years of menopause or under age 60. However, special considerations are needed for women who are outside those boundaries or for those that have risk factors for cardiovascular disease.
authors.affiliation: Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. shoupe@usc.edu
authors.forename: D
authors.initials: D
authors.lastname: Shoupe
mesh_terms: D000279:Administration, Cutaneous; D000367:Age Factors; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003704:Dementia / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000401:mortality / Q000592:standards; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors